Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 15/20 | 0.44 |
| ▸ | TDO2 | P48775 | 6/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.39 |
| ▸ | CYP2C8 | P10632 | 4/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 2/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21138046 | 0.91 | IDO1 (0.41) | IDO1TDO2CYP2C9CYP2C8CYP2C19 | |
| SCHEMBL21061130 | 0.83 | IDO1 (0.43) | IDO1TDO2CYP2C9CYP2C8CYP2C19 | |
| SCHEMBL21061181 | 0.74 | IDO1 (0.50) | IDO1TDO2CYP2C9CYP2C8 | |
| SCHEMBL7964040 | 0.72 | IDO1 (0.56) | IDO1TDO2CYP2C9CYP2C8CYP2C19 | |
| SCHEMBL22648495 | 0.72 | JAK2 (0.45) | IDO1TDO2CYP2C9CYP2C8CYP2C19 | |
| Trifluoroacetic Acid SCHEMBL22798906 | 0.72 | IDO1 (0.48) | IDO1TDO2CYP2C9CYP2C8CYP2C19 | |
| Hydrochloric Acid SCHEMBL22635786 | 0.71 | JAK2 (0.44) | IDO1TDO2CYP2C9CYP2C8CYP2C19 | |
| Trifluoroacetic Acid SCHEMBL27035428 | 0.71 | HRH4 (0.41) | HRH4HRH3HTR6 | |
| SCHEMBL21138139 | 0.70 | IDO1 (0.52) | IDO1TDO2CYP2C9CYP2C8KCNH2 | |
| Trifluoroacetic Acid SCHEMBL21271258 | 0.69 | HTR2C (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200352931-A1 | OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | Phenex Discovery Verwaltungs-GmbH (DE) | 2020-11-12 | — | — | US | disclosed |
| EP-3724177-A1 | OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | Phenex Discovery Verwaltungs-GmbH (DE) | 2020-10-21 | — | — | EP | disclosed |
| WO-2019115586-A1 | OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | Phenex Discovery Verwaltungs-GmbH (DE) | 2019-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200352931-A1 | OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | IDO1, IDO2, INMT | IDO1 1/4885TDO2 7/4885HRH4 385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.